News for Marker Therapeutics, Inc. (MRKR)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

On December 31, 2024, Blue Owl Capital Holdings LP (Trades, Portfolio) made a significant move by acquiring 554,250 shares of Marker Therapeutics Inc (MRKR). Th

Overview of the Recent Transaction On December 31, 2024, Alyeska Investment Group, L.P. (Trades, Portfolio) executed a significant transaction by acquiring 1,06

**media[496596]**

Israel-based Polyrizon Ltd. (PLRZ) is up over 217 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

Marker Therapeutics (MRKR) shares surged 11% after winning a $9.5M grant for clinical investigation of MT-601 in pancreatic cancer patients.

HOUSTON, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. ( MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation

Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

The allogeneic hematopoietic stem cell transplant market is expected to experience significant growth in the coming years, driven by advances in...

Marker Therapeutics (MRKR) has been awarded a $2M NIH grant to support a Phase 1 study of its drug candidate MT-601 in the treatment of non-Hodgkin’s lymphoma. Read more here.

Marker Therapeutics to receive non-dilutive funding from NIH Small Business Innovation Research Program based on preliminary clinical results and...

The IDH inhibitors market is expected to grow significantly in the coming years. This is due to the rising occurrence of IDH-mutated cancers, such as acute...

Marker Therapeutics stock gets Buy from Ladenburg citing CAR-T therapy potential

Jet.AI Inc. (JTAIZ) is up over 145% in Tuesday's pre-market trading. The following are some of the other stocks making big moves..

Jet.AI Inc. (JTAIZ) is up over 145% in Tuesday's pre-market trading. The following are some of the other stocks making big moves..

The acute myeloid leukemia market has a promising outlook with emerging therapies. The overall dynamics of the acute myeloid leukemia market are...

U.S. stocks traded higher toward the end of trading, with Nasdaq Composite gaining over 100 points on Monday. The Dow traded up 0.19% to 33,939.74 while the NASDAQ rose 1% to 13,391.54. The S&P 500, also rose, gaining, 0.47% to 4,319.22.

Read Analysts’ Upgrades for June 1st (BME, BMRRY, BPMC, DHR, DLTR, DMRC, FINV, FMX, GCHEF, HBCP) at ETF Daily News

Read Investment Analysts’ Downgrades for May 28th (AMZN, GBCI, HEI, HWKN, LLNW, LND, LSPD, LYEL, MBCN, MRKR) at ETF Daily News